Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[68Ga]Ga-Sa-DABI-4 PET Imaging for STING Expression
NCT06419361Phase 1Recruiting
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- May 2024
- Primary completion
- Dec 2025
- Modality
- Radiopharmaceutical
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of [68Ga]Ga-Sa-DABI-4, sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoint: Diagnostic efficacy at 15 days. Started May 2024; status: recruiting.
02
Drugs
[68Ga]Ga-Sa-DABI-4
Beyond the preview
Go deeper on NCT06419361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06419361.